Showing results (271-280 of 486) with videos related to
Sort By:
Pageof 49
Alimentary Pharmacology & Therapeutics|June 5, 2018
Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infectionF Wandrer, B Han, S Liebig, et al.Zeitschrift Fur Gastroenterologie|September 1, 1996
Reduced serum levels of a soluble form of the human adhesion receptor CD58 (LFA-3) in patients with inflammatory bowel diseaseJ C Hoffmann, M N Göke, J Evers, et al.Zeitschrift Fur Gastroenterologie|November 19, 2002
Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulationH T Arkenau, D O Stichtenoth, J C Frölich, et al.The Journal of Biological Chemistry|December 25, 2000
Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPbeta promoter suggests a new mechanism of transcriptional regulation by STAT3M Niehof, K Streetz, T Rakemann, et al.The American Journal of Gastroenterology|July 1, 1997
Altered bone metabolism in inflammatory bowel diseaseS C Bischoff, A Herrmann, M Göke, et al.Der Radiologe|September 24, 2002
[Indicators for longterm survival after the transjugular portosystemic intrahepatic shunt procedure]T D Kirchhoff, H Rosenthal, S Merkesdal, et al.Cancer Gene Therapy|November 4, 2000
IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomasM K Tietze, T Wuestefeld, Y Paul, et al.Journal of Viral Hepatitis|November 6, 2009
HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infectionJ Wiegand, S Meya, V Schlaphoff, et al.Journal of Molecular Biology|March 13, 2001
Structural organization of the hepatitis B virus minichromosomeC T Bock, S Schwinn, S Locarnini, et al.Lancet (London, England)|February 1, 1992
Anti-GOR and hepatitis C virus in autoimmune liver diseasesG Michel, A Ritter, G Gerken, et al.Pageof 49